1. Home
  2. WGS vs ARCB Comparison

WGS vs ARCB Comparison

Compare WGS & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

N/A

Current Price

$69.50

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Logo ArcBest Corporation

ARCB

ArcBest Corporation

N/A

Current Price

$125.08

Market Cap

2.9B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
WGS
ARCB
Founded
2017
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Trucking Freight/Courier Services
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.9B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
WGS
ARCB
Price
$69.50
$125.08
Analyst Decision
Strong Buy
Buy
Analyst Count
8
14
Target Price
$93.50
★ $166.85
AVG Volume (30 Days)
★ 722.5K
180.7K
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
★ 0.38%
EPS Growth
★ 62.37
N/A
EPS
N/A
★ N/A
Revenue
$427,539,000.00
★ $1,657,864,000.00
Revenue This Year
$12.70
$12.44
Revenue Next Year
$24.31
$7.93
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 39.97
12.56
52 Week Low
$32.21
$59.43
52 Week High
$170.87
$176.69

Technical Indicators

Market Signals
Indicator
WGS
ARCB
Relative Strength Index (RSI) 48.91 41.35
Support Level $68.55 $124.99
Resistance Level $73.04 $135.48
Average True Range (ATR) 5.62 4.51
MACD 0.96 -0.25
Stochastic Oscillator 81.47 17.43

Price Performance

Historical Comparison
WGS
ARCB

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

Share on Social Networks: